Category: Uncategorized

Re-acquired a Letter of Acceptance

Re-acquired a Letter of Acceptance from National Pharmaceutical
Regulatory Agency (NPRA)

LEARN MORE

Phase 1 Clinical Trial for Chondrogen

Commencement of Phase 1 Clinical Trial for Chondrogen with HUKM.

LEARN MORE

Acquisition of AIMST University Grant

Acquisition of AIMST University internal grant for safety and toxicology studies of Wharton’s Jelly derived mesenchymal stem cells.

LEARN MORE